Načítá se...
Recent advances in understanding idiopathic pulmonary fibrosis
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dismal prognosis of idiopathic pulmonary fibrosis (IPF) remains unchanged. The elaboration of international diagnostic criteria and disease stratification models based on clinical, physiological, radiolo...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000Research
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4890320/ https://ncbi.nlm.nih.gov/pubmed/27303645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8209.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|